Papers
1
Total Citations
34
H-Index
1
About
A Delest is a leading researcher in gynecologic oncology, with a primary focus on advancing minimally invasive surgical techniques and improving perioperative outcomes for cancer patients. Their most notable contribution is the landmark ROBOGYN-1004 trial, a randomized study comparing robot-assisted laparoscopy to conventional laparoscopy. This work, published in 2020 with 34 citations, provided critical evidence on severe perioperative morbidity, demonstrating that while robotic surgery offers technical advantages, it does not significantly reduce major complications compared to standard laparoscopy. This finding has shaped clinical guidelines and sparked ongoing debates about cost-effectiveness and patient selection in robotic surgery. Delest’s research is highly influential among surgeons and oncologists, as it directly informs decision-making in the operating room. By rigorously evaluating the risks and benefits of emerging technologies, Delest has established themselves as a key voice in evidence-based surgical oncology, helping to balance innovation with patient safety. Their work continues to inspire further trials and meta-analyses in the field.
Research Focus
Key Achievements
Top Papers
- 1